PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Lab Chip. Author manuscript; available in PMC 2017 August 2.
Published in final edited form as:
PMCID: PMC4970872
NIHMSID: NIHMS791360

Graphene-Based Microfluidics for Serial Crystallography

Abstract

Microfluidic strategies to enable the growth and subsequent serial crystallographic analysis of micro-crystals have the potential to facilitate both structural characterization and dynamic structural studies of protein targets that have been resistant to single-crystal strategies. However, adapting microfluidic crystallization platforms for micro-crystallography requires a dramatic decrease in the overall device thickness. We report a robust strategy for the straightforward incorporation of single-layer graphene into ultra-thin microfluidic devices. This architecture allows for a total material thickness of only ~1 μm, facilitating on-chip X-ray diffraction analysis while creating a sample environment that is stable against significant water loss over several weeks. We demonstrate excellent signal-to-noise in our X-ray diffraction measurements using a 1.5 μs polychromatic X-ray exposure, and validate our approach via on-chip structure determination using hen egg white lysozyme (HEWL) as a model system. Although this work is focused on the use of graphene for protein crystallography, we anticipate that this technology should find utility in a wide range of both X-ray and other lab on a chip applications.

Graphical Abstract

An external file that holds a picture, illustration, etc.
Object name is nihms791360u1.jpg

A robust strategy for the incorporation of graphene films as a diffusion barrier in ultra-thin X-ray compatible microfluidic devices.

Introduction

The application of micro-crystallography in structural biology has accelerated in recent years due to technological advances that enable the use of smaller and ever more brilliant X-ray beams.14 One goal of this micro-focused technology is to enhance the diffraction signal from micro-crystals by matching the size of the beam to the size of the crystal. Here, the signal enhancement comes from a reduction in the level of background scatter associated with the solvent or mounting support surrounding the crystal. It has also been suggested that smaller crystals may have a lower probability of defects, and thus have the potential to yield higher quality diffraction data.3,5,6 Furthermore, micro-crystals are critical to enable aspects of time-resolved protein crystallography.7 However, illumination of a smaller crystal volume with a greater X-ray flux increases the level of radiation damage experienced by the sample, and can dramatically decrease the usable lifetime of the crystal. In the case of next-generation, ultra-brilliant X-ray free-electron lasers (XFELs), the X-ray beam is so intense that the crystal is destroyed after a single X-ray pulse.8,9

To circumvent the issue of radiation damage and sample deterioration, ‘serial’ approaches to protein crystallography have become increasingly popular.9,10 These methods include the collection of data from a large number of independent volumes on a larger crystal,1117 and have transitioned recently to the collection of as little as a single frame of data from many smaller crystals. Complete datasets can then be obtained by merging data from hundreds, thousands, or even tens of thousands of crystals.10,11,15,1845 However, this data collection strategy suffers from the need to grow and efficiently manipulate a large number of fragile micro-crystals. Reported methods include the mounting of many crystals using traditional, loop-style holders,38,46 a variety of fixed-target architectures,4,6,11,4755 and different micro-crystal injection strategies10,52,5663 However, nearly all of these strategies have focused on transferring a pre-prepared slurry of micro-crystals onto a mount or into an injector, rather than coupling the processes of crystallization and X-ray analysis.6,10,47,48,62 This requirement for physical handling introduces the need for additional experimental procedures, can potentially damage fragile or sensitive crystals, and particularly in the case of micro-crystal injection jets, can lead to inefficient sample utilization6,10,47,48,62

The generation of a large number of high quality, isomorphous micro-crystals is an area where integrated microfluidic technologies excel. The small length-scales of microfluidic devices create an environment free of inertial or convective effects while providing exquisite control over local conditions and gradients. The reproducibility of the microfluidic environment allows for the formulation of identical crystallization conditions, without the uncontrolled variations in concentration that result from chaotic mixing in bulk crystallization strategies. The absence of these effects facilitates both the simultaneous growth of a large number of isomorphous crystals,17,30,31,33 and may provide additional benefits in crystal quality, as have been reported in other convection-free systems.6471

The benefits of microfluidic crystallization strategies are best realized when coupled with on-chip diffraction analysis. By leaving crystals undisturbed in a sealed environment, on-chip analysis avoids both challenges associated with harvesting a large number of tiny crystals from a microfluidic device and avoids the potential for crystal damage due to physical handling and/or exposure to the ambient environment. This approach also facilitates high levels of sample utilization by avoiding losses due to sample transfer or low hit-rates associated with continuous sample injection strategies.18,19,52,57 Unfortunately, the presence of the microfluidic device inherently introduces additional material into the X-ray path, resulting in signal attenuation and adversely affecting subsequent diffraction analysis.

Traditional microfluidic devices have been constructed out of millimeter-thick layers of glass, plastic, and/or poly(dimethylsiloxane) (PDMS).7276 However, the thickness of such materials does not permit the effective transmission of X-rays (Figure 1).77 Recently, a variety of microfluidic design strategies have been reported to try and address the challenge of creating an X-ray compatible microfluidic device. Nearly all of these approaches have focused on decreasing the thickness of device materials along the X-ray path to ~100 μm,6,2933,7891 a strategy that has been matched in more traditional well plate setups.2,28,9296 These ~100 μm-scale platforms have enabled the collection of X-ray diffraction data from a variety of both model and novel targets. Significantly, the quality of these data have been sufficient to enable detection of the small variations in signal necessary for both de novo structure determination via single-wavelength anomalous diffraction (SAD),30,80,81 and for capturing short-lived structural intermediates by Laue diffraction.32

Fig. 1
A comparison of the transmission factors I/I0 for varying thicknesses of PDMS, COC, and PMMA at an X-ray energy of 12.4 keV, or a wavelength of 1Å.

Despite these successes, microfluidic platforms for protein crystallography have typically been limited to data collection from relatively large crystals. This limitation is a consequence of needing to balance the strength of the diffraction signal from the crystal with losses associated with attenuation and background scattering from the device materials.31,32,48,97 For instance, in unrelated studies, relatively large crystals (50–200 μm) of hen egg white lysozyme (HEWL) were reported to diffract to a resolution limit of 1.55Å in a 120 μm-thick device,33 while 10–20 μm micro-crystals of HEWL in a 300 μm-thick device only diffracted to 2.5Å.6 While this comparison does not represent a well-controlled experiment, it is expected that resolution should suffer because of a decrease in signal-to-noise.97

Unfortunately, the development of even thinner devices has suffered from either intensive manufacturing requirements, or challenges related to sample stability and water loss. Many of the fixed-target approaches for serial crystallography rely on precision micro-manufacturing to fabricate device structures covered by an ultra-thin (50–500 nm-thick) silicon nitride membrane.47,51,55 These devices provide better stability against dehydration, compared to even thicker PDMS-based devices,6 and demonstrate the ability to collect high quality diffraction data from micro-crystals at a resolution equal to that observed for larger crystals.51 However, such devices cannot be manufactured with the same ease and low cost as soft lithographic and replica molding-based approaches, and are not amenable to the use of more easily-manufacturable ultra-thin polymer films because of challenges related to water loss and sample dehydration over time.

Here, we report a strategy for the straightforward incorporation of single-layer graphene into ultra-thin microfluidic devices to enable the in situ analysis of micro-crystals in a sample environment that is stable against evaporation for weeks. This work was inspired by two reports where graphene-wrapped protein crystals were shown to have good stability against dehydration and excellent signal-to-noise.98,99 To the best of our knowledge, this is the first report on the incorporation of large-sheet graphene into a microfluidic device to serve as a diffusion barrier against water loss.98102 We establish the long-term stability of our devices by quantifying the rate of water loss through our graphene-based thin films. We further validate our approach and demonstrate the utility of graphene-based thin film microfluidics for on-chip X-ray crystallography by comparing the levels of signal-to-noise obtainable for diffraction signals as a function of device thickness. Although this work is focused on the use of graphene for protein crystallography, we anticipate that this technology should find utility in a wide range of lab on a chip applications.

Materials and methods

Graphene synthesis and film transfer

Monolayer graphene was grown on a copper substrate by chemical vapor deposition in a quartz tube furnace (Plana Tech).100,102104 Solutions of 950PMMA A2 and 950PMMA A4 (poly(methylmethacrylate), Microchem) were spin coated (Specialty Coating Systems) onto the graphene film at 1000 rpm for 60 seconds, followed by curing at 120°C for 10 minutes to form a PMMA film thickness of approximately 180 nm and 500 nm respectively, as measured by profilometry (Dektak 3). The PMMA/graphene film was released from the copper substrate by back-etching of the copper in an aqueous solution of copper etchant solution (Transene) for 3 hours, followed by three rinse cycles in MilliQ water (18.2 MΩ-cm, Millipore Inc.) performed by floating the etched PMMA/graphene film on the surface of the water. The resultant film was then transferred directly from the surface of the water onto an adhesive-backed polyester film (McMaster Carr) for incorporation into the subsequent microfluidic device. Because of the way in which the graphene films are released from the copper substrate, it is most straightforward to transfer the PMMA/graphene film onto the backing support in such a way that the graphene film faces outward, rather than directly towards the channel. However, this assembly process can be performed in reverse, and no significant difference was observed in device performance comparing the two methods.

Device architecture and assembly

The overall chip architecture consists of five layers, which allow for various different functional layouts (Figure 2 and ESI Figures S8, S9). The fluidic channels of the device were defined by a 100-μm thick cyclic olefin copolymer (COC, Topas, 6013) film. The channel structure was cut into this film using a cutting plotter (Graphtec CE6000). The channel was then sealed on one side with a PMMA/graphene film, supported by an adhesive-backed polyester film (McMaster Carr) with cut-out features to define fluidic inlets and/or window areas (Figures 2,,33 and ESI Figures S8, S9). Here, the backing layer provides additional structural stability, while helping to define inlets, and providing a facile way to adhere the various layers together. Following assembly of the COC fluidic layer to the adhesive bottom layer containing a PMMA/graphene film, both the top and bottom halves of the device were coated with poly(dopamine) (PDA) to create a hydrophilic surface and facilitate channel wetting.105,106

Fig. 2
Schematic depiction of the fabrication scheme for thin-film graphene-based microfluidics, using a channel-based counter-diffusion as the example. (1) CVD-grown graphene on copper is first coated with a layer of PMMA, and then released from the copper ...
Fig. 3
(a) A microbatch chip mounted on the 14-ID-B beamline at BioCARS, oriented at −30° towards the high resolution camera. (b) Photograph of a counter-diffusion chip that has been filled with blue and red food dye to simulate on-chip mixing. ...

Poly(dopamine) (PDA) surface treatment

A 2 mg/mL solution of dopamine hydrochloride (Sigma) in 10 mM Tris buffer pH 8.5105,106 (Fisher, Molecular Biology grade) was freshly prepared and then carefully dropped onto the PMMA/graphene films to cover the entire channel surface (Figure 2 and ESI Figures S8, S9). The surfaces were allowed to incubate for at least 5 hours at room temperature (23°C) in a sealed Petri dish. Following treatment, the films were rinsed by dipping into MilliQ water three times and allowed to air dry before final device assembly and use.

Raman spectroscopy

Raman spectroscopy was used to validate the composition and quality of the resulting graphene-based films. Films were placed onto a silicon wafer coated with a 200 nm layer of silicon dioxide. Analysis was performed using a DXR™2xi Raman Imaging Microscope system (Thermo Scientific) with an incident beam of light at 633 nm on PMMA/graphene/PDA and PMMA/graphene films. These data were compared to the spectra for graphene, PMMA, and PDA-only films coated directly onto the silicon wafer (Figure 4).

Fig. 4
Raman spectra, demonstrating the expected signals for graphene, 500 nm PMMA, and PDA separately, and in our final composite films.

Permeability measurements

The permeation of water through our various thin film materials was quantified as a function of time by measuring the change in absorbance of an aqueous solution of red food dye (Kroger). Films of A2 PMMA, A4 PMMA, A2 PMMA/graphene, and A4 PMMA/graphene were adhered to an adhesive-coated polyester layer, as in Figure 2 and ESI Figure S8. These films, as well as a 100 μm COC were sealed with vacuum grease onto individual wells of a 96-well plate containing 300 μL of red food dye in water. The change in signal for these films was compared with wells that were left open to the air. All experiments were performed in triplicate. The solution absorbance was then monitored at 300 nm and 450 nm over time (Figure 5a) using a plate reader (BioTek). Photographs of the well plate allowed for visual characterization of changes in the sample volume (Figure 5b). In addition to direct measurements of water loss through films of the individual device materials, qualitative evaluation of water loss was evaluated directly using optical microscopy (ESI Figure S7).

Fig. 5
(a) Measurement of the absorbance of colored solutions as a function of time at 450 nm, demonstrating the water permeability of various PMMA, PMMA/graphene, and COC films. Both the thicker 100 μm COC film, and the two PMMA/graphene films show ...

Contact angle measurements

A PMMA/graphene film was transferred from the aqueous rinse solution onto a silicon wafer (graphene-side down) and allowed to air dry 3 hours to facilitate strong binding between the film and the wafer surface. A PDA treatment was then applied to the PMMA film. The contact angle of both a treated and an untreated PMMA/graphene film were measured using goniometry with MilliQ water (Ramé-Hart).

AFM characterization

Atomic force microscopy (AFM) was used to characterize the surface roughness of all films. Surface scans of PMMA-graphene and PDA coated PMMA-graphene ( ESI Figure S10) were acquired using the Cypher ES atomic force microscope (Asylum Research, Santa Barbara CA).107 Samples were imaged in AC mode with Tap-300G cantilevers (Budget Sensors).

Protein crystallization

A solution of 80 mg/mL hen egg white lysozyme (HEWL, Hampton Research Inc.) was prepared in 50 mM sodium acetate buffer (Fisher Scientific, ACS grade), pH 4.8. A precipitant solution was prepared, containing 2M sodium chloride (Sigma Aldrich, ACS reagent) in 50 mM sodium acetate, pH 4.8. For microbatch experiments (Figure 3c), 12 μL protein solution and 4 μL precipitant solution were pre-mixed and pipetted into the chip before the layers were sealed by simply pressing the adhesive layers together by hand. For counter-diffusion experiments using a channel-based chip architecture (Figure 3d), 12 μL protein solution and 4 μL precipitant solution were pipetted separately onto the two device inlets. Because of the hydrophilic PDA surface treatment, the solutions wetted the channels and flowed into the device. The chip can be filled either by the sequential or simultaneous addition of crystallization solutions. However, due to the impermeability of the PMMA/graphene film, simultaneous filling of crystallization and precipitant solutions can lead to trapping of air within the device. The filled chip was placed into a Petri dish alongside a microcentrifuge containing 200 μL of DI water. The Petri dish was sealed with Parafilm (Thermo Scientific), and stored at 4°C. For both crystallization strategies, large lysozyme crystals (>100 μm) formed overnight. Crystals were visualized using a Zeiss V12 stereomicroscope with cross-polarizers (Carl Zeiss Microscopy LLC).

On-chip X-ray diffraction

Data were collected in polychromatic mode at 12 keV (1.03 Å, 5% bandwidth) on the 14-ID-B beamline at the Advanced Photon Source at Argonne National Laboratory.108 The microfluidic chips were mounted directly on the [var phi] spindle of the goniometer using a modified magnetic mount (Hampton Research; Figure 3a). Positioning and alignment of the chips was performed using a high- resolution camera oriented at 30° with respect to the X-ray beam and a medium-resolution camera oriented at 60°, slightly modified from previous reports.31,32 This setup allowed for a range of motion of ±5 mm in x (focus, along the direction of the X-ray beam), ±6 mm in y (vertical with respect to the direction X-ray beam), and ±60 mm in z (horizontal with respect to the X-ray beam). Sample visualization and positioning were performed using an in-house graphical user interface at the 14-ID-B beamline. Sample positioning was achieved using a click-and- translate routine coupled to the high- and medium- resolution cameras. Sample centering along the path of the X- ray beam was achieved by visually focusing the sample, taking advantage of the very small depth of field of the high-resolution camera. The interface enabled identification and alignment of crystals on chip. BioCARS LaueCollect software was used for subsequent data acquisition.

Data were collected from microfluidic chips oriented between 45° and 45° with respect to the X-ray beam. The large size (~300 μm) and robustness of the HEWL crystals, combined with the small X-ray beam size (35 x 35 μm2 FWHM), permitted the collection of multiple frames (3 or 4, see Table 1 and ESI Table S2) of data from a large number of fresh crystal volumes on each individual crystal at room temperature. Data were typically collected at 3° intervals over the range of 45° and 45°. This spacing was chosen to enable optimal coverage of reciprocal space given the available X-ray bandwidth. Complete data sets were obtained by merging data taken from multiple volumes of the same crystal. We compare four different crystals grown and/or analysed under different conditions (see Figure 6, Table 1, and ESI Table S2). A Rayonix MX340-HS detector was used with a sample-to-detector distance of 175 mm. Diffraction data were collected using a 1.5 μs exposure with the storage ring operating in 24-bunch mode (11 consecutive X-ray pulses of 100ps duration).

Fig. 6
(a) One-dimensional integrated X-ray intensity profiles showing the relative strength of the observed diffraction signal from a HEWL crystal compared to the noise resulting from background scattering due to the presence of device materials as a function ...
Table 1
Crystallographic statistics for data obtained using on-chip micro-diffraction Laue analysis of various HEWL crystals.

Data Analysis

Laue diffraction images were processed using the Precognition/Epinorm software (Renz Research; Table 1). Each crystal was processed separately. Microbatch data were integrated to 1.40 Å resolution, counter-diffusion data to 1.45Å and ultimately merged to a final resolution that was chosen both to maintain a completeness in the highest resolution shell, of at least 25%, provided that I/σ(I) remains above 3. Subsequent processing of crystallographic data sets is carried out using both the CCP4 suite of programs109 and PHENIX110. Structure refinement (Table 1) was carried out using PHENIX.refine starting from PDB model 193L70 in a fully automated fashion for 20 cycles, including optimization of atomic coordinates, real-space refinement, individual B-factors, TLS parameters and occupancies, while taking advantage of simulated annealing (Cartesian), automatically correcting N/Q/H errors, and updating waters.

Analysis of the background signal-to-noise (Figure 6) was done using the Nika software suite for 2D diffraction data reduction in Igor Pro (Wavemetrics Inc.).111 Integration of diffraction images in 2θ with log binning was performed using the calibrated beam center and sample-to-detector distance obtained from geometry refinement in Precognition.

Results and discussion

The goal of this work was the development of an ultra-thin X-ray compatible microfluidic platform to enable on-chip X-ray diffraction analysis of protein crystals with negligible contributions from the device materials. To this end, we developed a straightforward method for the incorporation of large-area, single-layer graphene films to serve as both X-ray compatible windows and as a diffusion barrier to prevent evaporative losses from the device. Our ultimate objective is to enable serial crystallography of micro-crystals (< 10 μm in size) for both de novo structure determination and time-resolved crystallography, where the ability to detect small variations in the overall X-ray signal is critical. To achieve the low levels of background noise and high signal transmission necessary for these applications, we established design criteria for our X-ray transparent microfluidic device. We considered three main aspects of the interaction of our device materials with X-rays: (i) attenuation of the X-ray signal, (ii) background noise resulting from diffuse scattering, and (iii) the strength of the diffraction resulting from a crystal.

Attenuation, or the change in intensity of the X-ray beam can be calculated for any material based on the atomic weight of the atoms present, the density of the material, and the wavelength of interest (see ESI Table S1 and Figure S1).77,112 Thus, we can minimize attenuation effects by decreasing the atomic weight of the atoms present in the material, decreasing the density, and/or decreasing the thickness. Based on these calculations, we show that at a wavelength of 1Å (12.4 keV), achieving transmission levels of 99% would necessitate decreasing the thickness of our device to only 1 μm of PDMS, or approximately 10 μm of an organic polymer such as COC or PMMA. Achieving 99.9% transmission would require 200 nm-thick PDMS, or approximately 900 nm-thick COC or PMMA (Figure 1 and ESI Figure S2). However, most sub-micron polymeric films suffer from relatively high rates of water permeation. We therefore developed a strategy for coupling sub-micron polymer films with large-area, single-layer sheets of graphene to create a diffusion barrier against water loss.

Traditional methods for graphene-transfer have taken advantage of thin-film PMMA as a support layer to aid during transfer of the graphene films from the copper substrate where they are grown to a functional device.104 Here, we adapted this procedure to facilitate incorporation of a sub-micron polymer film to serve as an impermeable X-ray window for our microfluidic protein crystallography platforms. Single- layer graphene was coated with a ~500 nm-thick layer of PMMA and transferred to pre-cut adhesive polyester substrates containing the appropriate features to define a window and/or inlet structures for the top and bottom of the device (Figure 2 and ESI Figure S8). The presence of the adhesive helped to secure both the PMMA/graphene films in place, as well as adhering these top and bottom layers to a spacer layer of 100 μm-thick COC, pre-cut to define the microfluidic features of the device. This strategy took advantage of commercially-available materials and avoided the need to apply a separate adhesive treatment that would potentially increase the overall thickness of the device. Furthermore, we anticipate that this strategy could be easily adapted to work with a variety of alternative strategies for defining microfluidic channels, including roll-to-roll manufacturing.

We utilized this manufacturing strategy to develop simple microfluidic geometries to enable microbatch and counter-diffusion crystallization experiments (Figures 2, ,3).3). However, the various polymeric surfaces present in our device proved to be relatively hydrophobic, such that our crystallization solutions would not easily wet and flow into a microfluidic channel. We overcame this difficulty through the application of an ultra-thin, hydrophilic, PDA-based surface treatment.105 Here, a solution of dopamine at pH 8.5 was allowed to incubate on the various surfaces of our microfluidic channel (Figure 2 and ESI Figure S8). Under basic conditions, dopamine has been shown to polymerize and create a ~10 nm-thick hydrophilic surface coating.105,113 Contact angle measurements showed a change in wetting angle from 74° before treatment, to 36° after treatment ( ESI Figure S11). We further confirmed the presence of both PDA and the integrity of our graphene film via Raman spectroscopy (Figure 4). This level of wetting proved to be sufficient for aqueous solutions to easily wet and flow into our device (Figure 3b).

Our main motivation for incorporating graphene into our microfluidic device architecture was to create a diffusion barrier to minimize the loss of water from our device. We tested the effectiveness of various polymeric films on preventing the evaporative loss of water in a well plate-style assay. Both visual inspection of the various wells (Figure 5a and ESI Figure S6) and quantitative analysis via absorbance measurements at 300 nm ( ESI Figure S6a) and 450 nm (Figure 5b) demonstrated the efficacy of single layer of graphene as a diffusion barrier against water loss. Under our experimental conditions, complete evaporation of an open well occurred over the course of approximately 48 hours, while the presence of a 180 nm-thick A2 PMMA film only extended this lifetime to 72 hours. However, the addition of a single layer of graphene decreased the rate of water loss such that only minimal water loss was observed after 360 hours (15 days). Similarly, a 500 nm-thick A4 PMMA film showed complete evaporation after 120 hours, but the addition of graphene resulted in negligible water loss over the entire course of our experiment. These graphene-based, sub-micron films provided the same level of protection against water loss as a 100 μm-thick film of COC, a material known for its low water permeability.114 Furthermore, prior reports have demonstrated that the use of multiple layers of graphene can further improve the barrier properties of the film.100

We then extended our water permeation experiments from a simple film geometry, to the fully assembled microfluidic device architecture. Visual inspection of optical micrographs indicated no significant water loss over the course of 96 hours (4 days) for microbatch devices where the sample chamber was completely enclosed between two gas impermeable PMMA/graphene films ( ESI Figure S7a). However, for the case of the counter-diffusion chip, if only the main sample chamber was protected by PMMA/graphene films, then significant water loss was observed from the unprotected areas of the device over the course of ~1 day ( ESI Figure S7b). While such evaporative losses can be mitigated by sample incubation in a controlled humidity environment, future device designs will incorporate complete isolation of the sample environment within a graphene film.

Having demonstrated the efficacy of our device materials to protect against dehydration and enable long-term sample incubation, we set up microbatch and counter-diffusion crystallization trials using HEWL. Large crystals (>100 μm, Figure 3c,d) formed overnight for both of these methods, and were stable in the lab for days at 4°C. As a precaution, devices were placed into a petri dish along with a reservoir of water and sealed. These samples easily survived the rigors associated with overnight shipping to the synchrotron. This demonstration of stability significantly enhances the potential utility of these devices by allowing users to prepare crystallization trials at their home laboratory, incubate as needed, and transport their samples for analysis with the same relative ease as with more traditional samples.

We next investigated the levels of signal-to-noise achievable for on-chip X-ray diffraction measurements. While attenuation calculations (Figure 1 and ESI Figure S2) describe the total signal lost via transmission through a material, this does not characterize the observed signal-to-noise. Here, we investigated the level of background scatter observed for our various device materials as a function of resolution. The introduction of a thin A2 PMMA film resulted in an approximately 10-fold increase in the observed background scattering, compared to air only ( ESI Figure S3). No significant change in signal was observed with the subsequent addition of either graphene or a PDA treatment, and a minimal increase in scattering was observed when the PMMA film was increased from 180 nm-thick A2, to 500 nm-thick A4 PMMA. However, a further increase in scattering was observed with the addition of a 100 μm-thick film of COC. The signal for COC showed increases in the overall levels of background noise, with resolution-dependent scattering bands present at approximately 2.5Å and 5Å, characteristic of the internal structure of the polymer. It should be noted that Laue diffraction, due to the polychromatic nature of the X-ray beam, typically suffers from higher background and thus poorer signal-to-noise than monochromatic X-ray diffraction methods. Consequently, the experiments performed here are a powerful demonstration of the utility of our approach.

While basic characterization of the background scattering for the device materials was performed with the sample mounted perpendicular to the incident X-ray beam, protein structure determination can require sample rotation to enable data collection from a variety of different crystal orientations. Thus, we must consider not only the thickness of the device materials in terms of a minimal path length, but based on sample orientation. We therefore calculated the relative path length through a film as a function of rotation angle ( ESI Figure S4). This path length varies as 1/cos(ϕ), and diverges as the angle ϕ approaches 90°. However, because of low signal attenuation, we are able to maintain a transmission of 99.9% of the incident signal through a rotation of +/− 86° from normal. This large range of rotation means that for low-symmetry space-group crystals, or for anomalous diffraction measurements, our devices are able to access 344° out of a possible 360° rotation at a better than 99.9% level. If we decrease our level of acceptable signal attenuation to 90% of the incident beam intensity, we can achieve +/− 89.5° of rotation from normal, meaning that only 2° of data would be out of reach. These high levels of transmission and the ability to access a wide range of sample orientations are a dramatic improvement over previously-reported PDMS/COC based devices which enable a maximum of only 77% of the incident X-ray intensity when normal to the incident beam.3033,115117

Having characterized the X-ray profile of our device materials, we next investigated the effect of this background scattering on the signal-to-noise associated with on-chip X-ray diffraction measurements. All images were well exposed, typically with several saturated diffraction spots (~65,000 counts). A comparison of both the 2D diffraction images and the corresponding 1D integrations shows the presence of strong diffraction peaks and an additional diffuse signal around 3Å, which we attribute to the presence of solvent (Figure 6 and ESI Figure S5).98 The observed strength of the diffraction signal decreases relative to the background noise at higher resolution, as expected. It should be noted that the data presented in Figure 6 and ESI Figure S5 is the result of integration in 2θ across the entire image, rather than along a line. Thus, the presence of multiple diffraction peaks at nearly the same resolution could result in apparent broadening of the integrated signal.

The benefit of our ultra-thin device materials can be observed through a comparison of the observed signal-to-noise from a crystal analysed in one of our PMMA/graphene-based microbatch devices, compared with a second crystal from the same device that opportunistically grew underneath the COC spacer layer. Comparing the data from these two crystals, we can clearly observe a decrease in signal quality as a result of the higher background signal from the 100 μm-thick COC layer, both visually in the 2D diffraction images, and more quantitatively in the 1D integrations (Figure 6 and ESI Figure S5). We have previously struggled to observe diffraction for relatively small crystals in a PDMS/COC device, and posit that the balance of signal-to-noise observed here explains our observations.

Finally, we collected complete datasets for different individual crystals using a micro-focused X-ray beam to enable the collection of small wedges of data from distinct locations across a crystal. We did not observe a significant variation in data obtained from different crystals within the same device (microbatch), or between crystallization techniques (microbatch vs. counter-diffusion; Table 1 and ESI Table S2). However, in general, the counter-diffusion method would be expected to result in more reproducible crystal growth, due to the precise control over concentration gradients, diffusion, and mixing afforded by microfluidic devices.30,31,33

We also compared data from the two microbatch-grown crystals described in Figure 6 and ESI Figure S5, examining the effect of an obscuring 100 μm-thick COC layer. Interestingly, we did not observed a significant decrease in resolution for the crystal present under the thicker COC film. This result may be due to the relatively strong diffraction signals expected from our large crystals. High quality crystallographic statistics were observed for all samples; however, the presence of the thick COC film did correspond with an increase in the values for Rmerge, and a decrease in signal-to-noise (i.e., <F/σ(F)>).

A closer analysis of <F/σ(F)> as a function of resolution (Figure 7) demonstrated that the increased attenuation and background scatter resulting from the presence of a 100 μm-thick COC layer had a negative effect on the overall sensitivity of the measurement. This decrease in signal-to-noise was observed despite similar, levels of completeness and redundancy in the overall dataset, compared with data collected through PMMA/graphene windows (Table 1, ESI Table S2, and Figure S12). The effect of background material on signal-to-noise can be particularly highlighted with respect to a significant decrease in <F/σ(F)> at a resolution of ~2.5Å, corresponding to one of the scattering bands observed for COC (Figure 6 and ESI Figure S5). We were unable to directly observe the impact of the larger scattering band observed at ~5.0Å, due to the range of resolutions over which the binned <F/σ(F)> data were provided by the processing software. However, we anticipate that contributions from this large scattering band are what cause the large difference in <F/σ(F)> at low resolution between the samples containing COC and those without.

Fig. 7
Graph of signal-to-noise <F/σ(F)> as a function of resolution for the four datasets shown in Table S2. The final resolution of the dataset is indicated in the legend. A significant decrease in <F/σ(F)> is ...

Examination of the electron density maps generated from these various datasets show similar levels of structural detail, as would be expected from data extending to ~1.40Å (Figure 8 and ESI Figure S13). The quality of the data allows for unambiguous interpretation of structural details, including side-chain conformations, the presence of aromatic groups, and the location of bound water molecules. Statistical measures associated with structure refinement (Rwork, and Rfree) were very good, and showed no significant dependence on the details of data collection.

Fig. 8
2FoFc electron density map of HEWL grown in microbatch to 1.40Å. The map was contoured at 2σ and superimposed over a licorice representation of the protein structure surrounding Trp108.

It should be noted that the excellent levels of signal-to-noise obtained for all of these samples, as well as the informative differences between samples, and high levels of structural detail were observed based on the diffracted intensity produced by a 1.5 μs polychromatic X-ray exposure (11 consecutive X-ray pulses of 100 ps duration). The next phase of testing will focus on the serial analysis of micro-crystals. We will also investigate the potential for performing data collection using only a single ~100 ps X-ray pulse. Such studies, particularly coupled with serial data collection strategies, have the potential to “out-run” the adverse effects of secondary radiation damage, such as radical generation and the breakage of chemical bonds to enhance the relevance of the resultant data.31,118

Conclusions

In summary, we have presented a straightforward method for the incorporation of single-layer graphene into ultra-thin, X-ray compatible microfluidic devices. We have demonstrated the utility of graphene as a diffusion barrier to mitigate the effects of evaporation over the course of several weeks. We further validated our approach via the on-chip structure determination of HEWL as a model system to facilitate quantification of the effects of device thickness on the signal-to-noise of the diffraction measurement and subsequent structure determination efforts. Looking forward, these graphene-enhanced, ultra-thin device fabrication strategies hold tremendous promise for enabling the on-chip crystallization and subsequent serial crystallographic analysis of micro-crystals at synchrotron sources, and could be further scaled to enable the analysis of nano-crystals at XFELs.

The ability to collect data from micro-crystals has the potential to enable structure determination from targets that have proven resistant to the growth of larger crystals for more traditional analyses. This approach would take advantage of microfluidics to grow a large number of high-quality, isomorphous crystals while facilitating efficient, high-throughput serial diffraction analysis without the need for sample handling and mounting. Additionally, these types of serial methods can be used to potentially “out-run” radiation damage by, coupling single-shot analysis of a large number of crystals with fast data collection.118 Strategies for implementing this type of approach include single X-ray pulse Laue diffraction at synchrotron sources, as well as more advanced, XFEL-based methods.

Ultimately, we see the intersection of microfluidics, micro-crystallography, and fast data collection as an opportunity to enable the study of protein structural dynamics. To this end, integrated microfluidic fluid-handling capabilities could be harnessed to enable chemical triggering (e.g., substrate addition or a pH jump) to investigate a wide range of biologically and medically relevant protein targets that have thus far been resistant to time-resolved studies. For these studies, micro-crystals are critical to enable efficient diffusion of the triggering species into the crystal at a timescale faster than the enzymatic reaction.7 Building on this idea, it would also be possible to extend these types of studies to examine multiple variables (e.g., structural changes due to ligand binding as a function of time, salt concentration, and pH) to expand the scope and context of the resultant dynamic structural information.119

Supplementary Material

ESI

Acknowledgments

We would like to acknowledge Ashley Kaiser for her assistance with graphene synthesis, Prof. Jungwoo Lee and Jun-Goo Kwak for help with the cutting plotter, Prof. Lili He for her assistance with Raman spectroscopy, Prof. Stephen S. Nonnenmann for the use of his atomic force microscope, Kerianne Dobosz from the Schiffman lab and Minchao Zhang from the McCarthy lab for assistance with contact angle measurements, Zoey Meng for assistance with profilometry, George Chang from the Emrick lab for suggestions regarding PDA treatments, and Rui Pereira for helpful discussions. K.W.K. was supported by National Research Service Award T32 GM008515 from the National Institutes of Health. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of BioCARS was also supported by the National Institute of General Medical Sciences of the National Institutes of Health under grant number R24GM111072. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Footnotes

Electronic Supplementary Information (ESI) available: Details of X-ray attenuation calculations, background scattering and signal-to-noise analysis, device fabrication, permeability tests, AFM characterization, contact angle measurements, and additional crystallographic analysis and electron density maps. See DOI: 10.1039/x0xx00000x

References

1. Smith JL, Fischetti RF, Yamamoto M. Curr Opin Struct Biol. 2012;22:602–612. [PMC free article] [PubMed]
2. Axford D, Owen RL, Aishima J, Foadi J, Morgan AW, Robinson JI, Nettleship JE, Owens RJ, Moraes I, Fry EE, Grimes JM, Harlos K, Kotecha A, Ren J, Sutton G, Walter TS, Stuart DI, Evans G. Acta Crystallogr, Sect D: Biol Crystallogr. 2012;68:592–600. [PMC free article] [PubMed]
3. Cusack S, Belrhali H, Bram A, Burghammer M, Perrakis A, Riekel C. Nat Struct Mol Biol. 1998;5:634–637. [PubMed]
4. Riekel C. NanoWorld J. 2015;1:71–76.
5. Kupitz C, Grotjohann I, Conrad CE, Roy-Chowdhury S, Fromme R, Fromme P. Philos Trans R Soc, B. 2014;369:20130316. [PMC free article] [PubMed]
6. Lyubimov AY, Murray TD, Koehl A, Araci IE, Uervirojnangkoorn M, Zeldin OB, Cohen AE, Soltis SM, Baxter EL, Brewster AS, Sauter NK, Brunger AT, Berger JM. Acta Crystallogr, Sect D: Biol Crystallogr. 2015;71:928–940. [PMC free article] [PubMed]
7. Schmidt M. Adv Condens Matter Phys. 2013;2013:167276.
8. Chapman HN, Caleman C, Timneanu N. Philos Trans R Soc, B. 2014;369:20130313. [PMC free article] [PubMed]
9. Hunter MS, Fromme P. Methods. 2011;55:387–404. [PMC free article] [PubMed]
10. Chapman HN, Fromme P, Barty A, White TA, Kirian RA, Aquila A, Hunter MS, Schulz J, DePonte DP, Weierstall U, Doak RB, Maia FRNC, Martin AV, Schlichting I, Lomb L, Coppola N, Shoeman RL, Epp SW, Hartmann R, Rolles D, Rudenko A, Foucar L, Kimmel N, Weidenspointner G, Holl P, Liang M, Barthelmess M, Caleman C, Boutet S, Bogan MJ, Krzywinski J, Bostedt C, Bajt S, Gumprecht L, Rudek B, Erk B, Schmidt C, Hömke A, Reich C, Pietschner D, Strüder L, Hauser G, Gorke H, Ullrich J, Herrmann S, Schaller G, Schopper F, Soltau H, Kühnel K-U, Messerschmidt M, Bozek JD, Hau-Riege SP, Frank M, Hampton CY, Sierra RG, Starodub D, Williams GJ, Hajdu J, Timneanu N, Seibert MM, Andreasson J, Rocker A, Jönsson O, Svenda M, Stern S, Nass K, Andritschke R, Schröter C-D, Krasniqi F, Bott M, Schmidt KE, Wang X, Grotjohann I, Holton JM, Barends TRM, Neutze R, Marchesini S, Fromme R, Schorb S, Rupp D, Adolph M, Gorkhover T, Andersson I, Hirsemann H, Potdevin G, Graafsma H, Nilsson B, Spence JCH. Nature. 2011;469:73–77. [PMC free article] [PubMed]
11. Hirata K, Shinzawa-Itoh K, Yano N, Takemura S, Kato K, Hatanaka M, Muramoto K, Kawahara T, Tsukihara T, Yamashita E, Tono K, Ueno G, Hikima T, Murakami H, Inubushi Y, Yabashi M, Ishikawa T, Yamamoto M, Ogura T, Sugimoto H, Shen JR, Yoshikawa S, Ago H. Nat Methods. 2014;11:734–736. [PubMed]
12. Ihee H, Rajagopal S, Srajer V, Pahl R, Anderson S, Schmidt M, Schotte F, Anfinrud PA, Wulff M, Moffat K. Proc Natl Acad Sci U S A. 2005;102:7145–7150. [PubMed]
13. Jung YO, Lee JH, Kim J, Schmidt M, Moffat K, Srajer V, Ihee H. Nat Chem. 2013;5:212–220. [PMC free article] [PubMed]
14. Ren Z, Perman B, Srajer V, Teng TY, Pradervand C, Bourgeois D, Schotte F, Ursby T, Kort R, Wulff M, Moffat K. Biochemistry. 2001;40:13788–13801. [PubMed]
15. Tenboer J, Basu S, Zatsepin N, Pande K, Milathianaki D, Frank M, Hunter M, Boutet S, Williams GJ, Koglin JE, Oberthur D, Heymann M, Kupitz C, Conrad C, Coe J, Roy-Chowdhury S, Weierstall U, James D, Wang D, Grant T, Barty A, Yefanov O, Scales J, Gati C, Seuring C, Srajer V, Henning R, Schwander P, Fromme R, Ourmazd A, Moffat K, van Thor JJ, Spence JCH, Fromme P, Chapman HN, Schmidt M. Science. 2014;346:1242–1246. [PMC free article] [PubMed]
16. Tripathi S, Srajer V, Purwar N, Henning R, Schmidt M. Biophys J. 2012;102:325–332. [PubMed]
17. Bowler MG, Bowler MW. Acta Crystallogr, Sect F: Struct Biol Cryst Commun. 2013;70:127–132.
18. Boutet S, Lomb L, Williams GJ, Barends TRM, Aquila A, Doak RB, Weierstall U, DePonte DP, Steinbrener J, Shoeman RL, Messerschmidt M, Barty A, White TA, Kassemeyer S, Kirian RA, Seibert MM, Montanez PA, Kenney C, Herbst R, Hart P, Pines J, Haller G, Gruner SM, Philipp HT, Tate MW, Hromalik M, Koerner LJ, van Bakel N, Morse J, Ghonsalves W, Arnlund D, Bogan MJ, Caleman C, Fromme R, Hampton CY, Hunter MS, Johansson LC, Katona G, Kupitz C, Liang M, Martin AV, Nass K, Redecke L, Stellato F, Timneanu N, Wang D, Zatsepin NA, Schafer D, Defever J, Neutze R, Fromme P, Spence JCH, Chapman HN, Schlichting I. Science. 2012;337:362–364. [PMC free article] [PubMed]
19. Johansson LC, Arnlund D, White TA, Katona G, DePonte DP, Weierstall U, Doak RB, Shoeman RL, Lomb L, Malmerberg E, Davidsson J, Nass K, Liang M, Andreasson J, Aquila A, Bajt S, Barthelmess M, Barty A, Bogan MJ, Bostedt C, Bozek JD, Caleman C, Coffee R, Coppola N, Ekeberg T, Epp SW, Erk B, Fleckenstein H, Foucar L, Graafsma H, Gumprecht L, Hajdu J, Hampton CY, Hartmann R, Hartmann A, Hauser G, Hirsemann H, Holl P, Hunter MS, Kassemeyer S, Kimmel N, Kirian RA, Maia FRNC, Marchesini S, Martin AV, Reich C, Rolles D, Rudek B, Rudenko A, Schlichting I, Schulz J, Seibert MM, Sierra RG, Soltau H, Starodub D, Stellato F, Stern S, Strüder L, Timneanu N, Ullrich J, Wahlgren WY, Wang X, Weidenspointner G, Wunderer C, Fromme P, Chapman HN, Spence JCH, Neutze R. Nat Methods. 2012;9:263–265. [PMC free article] [PubMed]
20. Johansson LC, Arnlund D, Katona G, White TA, Barty A, DePonte DP, Shoeman RL, Wickstrand C, Sharma A, Williams GJ, Aquila A, Bogan MJ, Caleman C, Davidsson J, Doak RB, Frank M, Fromme R, Galli L, Grotjohann I, Hunter MS, Kassemeyer S, Kirian RA, Kupitz C, Liang M, Lomb L, Malmerberg E, Martin AV, Messerschmidt M, Nass K, Redecke L, Seibert MM, Sjöhamn J, Steinbrener J, Stellato F, Wang D, Wahlgren WY, Weierstall U, Westenhoff S, Zatsepin NA, Boutet SEB, Spence JCH, Schlichting I, Chapman HN, Fromme P, Neutze R. Nat Commun. 2013;4:2911. [PMC free article] [PubMed]
21. Barends TRM, Foucar L, Botha S, Doak RB, Shoeman RL, Nass K, Koglin JE, Williams GJ, Boutet S, Messerschmidt M, Schlichting I. Nature. 2013;505:244–247. [PubMed]
22. Demirci H, Sierra RG, Laksmono H, Shoeman RL, Botha S, Barends TRM, Nass K, Schlichting I, Doak RB, Gati C, Williams GJ, Boutet S, Messerschmidt M, Jogl G, Dahlberg AE, Gregory ST, Bogan MJ. Acta Crystallogr, Sect F: Struct Biol Cryst Commun. 2013;69:1066–1069. [PMC free article] [PubMed]
23. Kern J, Alonso-Mori R, Tran R, Hattne J, Gildea RJ, Echols N, Glockner C, Hellmich J, Laksmono H, Sierra RG, Lassalle-Kaiser B, Koroidov S, Lampe A, Han G, Gul S, DiFiore D, Milathianaki D, Fry AR, Miahnahri A, Schafer DW, Messerschmidt M, Seibert MM, Koglin JE, Sokaras D, Weng TC, Sellberg J, Latimer MJ, Grosse-Kunstleve RW, Zwart PH, White WE, Glatzel P, Adams PD, Bogan MJ, Williams GJ, Boutet S, Messinger J, Zouni A, Sauter NK, Yachandra VK, Bergmann U, Yano J. Science. 2013;340:491–495. [PMC free article] [PubMed]
24. Kern J, Tran R, Alonso-Mori R, Koroidov S, Echols N, Hattne J, Ibrahim M, Gul S, Laksmono H, Sierra RG, Gildea RJ, Han G, Hellmich J, Lassalle-Kaiser B, Chatterjee R, Brewster AS, Stan CA, Ockner CG, Lampe A, DiFiore DOR, Milathianaki D, Fry AR, Seibert MM, Koglin JE, Gallo E, Uhlig J, Sokaras D, Weng TC, Zwart PH, Skinner DE, Bogan MJ, Messerschmidt M, Glatzel P, Williams GJ, Boutet SEB, Adams PD, Zouni A, Messinger J, Sauter NK, Bergmann U, Yano J, Yachandra VK. Nat Commun. 2014;5:4371. [PMC free article] [PubMed]
25. Kern J, Hattne J, Tran R, Alonso-Mori R, Laksmono H, Gul S, Sierra RG, Rehanek J, Erko A, Mitzner R, Wernet P, Bergmann U, Sauter NK, Yachandra V, Yano J. Philos Trans R Soc, B. 2014;369:20130590. [PMC free article] [PubMed]
26. Redecke L, Nass K, DePonte DP, White TA, Rehders D, Barty A, Stellato F, Liang M, Barends TR, Boutet S, Williams GJ, Messerschmidt M, Seibert MM, Aquila A, Arnlund D, Bajt S, Barth T, Bogan MJ, Caleman C, Chao TC, Doak RB, Fleckenstein H, Frank M, Fromme R, Galli L, Grotjohann I, Hunter MS, Johansson LC, Kassemeyer S, Katona G, Kirian RA, Koopmann R, Kupitz C, Lomb L, Martin AV, Mogk S, Neutze R, Shoeman RL, Steinbrener J, Timneanu N, Wang D, Weierstall U, Zatsepin NA, Spence JCH, Fromme P, Schlichting I, Duszenko M, Betzel C, Chapman HN. Science. 2013;339:227–230. [PMC free article] [PubMed]
27. Koopmann R, Cupelli K, Redecke L, Nass K, DePonte DP, White TA, Stellato F, Rehders D, Liang M, Andreasson J, Aquila A, Bajt S, Barthelmess M, Barty A, Bogan MJ, Bostedt C, Boutet S, Bozek JD, Caleman C, Coppola N, Davidsson J, Doak RB, Ekeberg T, Epp SW, Erk B, Fleckenstein H, Foucar L, Graafsma H, Gumprecht L, Hajdu J, Hampton CY, Hartmann A, Hartmann R, Hauser G, Hirsemann H, Holl P, Hunter MS, Kassemeyer S, Kirian RA, Lomb L, Maia FRNC, Kimmel N, Martin AV, Messerschmidt M, Reich C, Rolles D, Rudek B, Rudenko A, Schlichting I, Schulz J, Seibert MM, Shoeman RL, Sierra RG, Soltau H, Stern S, Strüder L, Timneanu N, Ullrich J, Wang X, Weidenspointner G, Weierstall U, Williams GJ, Wunderer CB, Fromme P, Spence JCH, Stehle T, Chapman HN, Betzel C, Duszenko M. Nat Methods. 2012;9:259–262. [PMC free article] [PubMed]
28. Wang X, Peng W, Ren J, Hu Z, Xu J, Lou Z, Li X, Yin W, Shen X, Porta C. Nat Struct Mol Biol. 2012;19:424–429. [PMC free article] [PubMed]
29. Heymann M, Opthalage A, Wierman JL, Akella S, Szebenyi DM, Gruner SM, Fraden S. IUCrJ. 2014;1:349–360. [PMC free article] [PubMed]
30. Perry SL, Guha S, Pawate AS, Bhaskarla A, Agarwal V, Nair SK, Kenis PJA. Lab Chip. 2013;13:3183–3187. [PMC free article] [PubMed]
31. Perry SL, Guha S, Pawate AS, Henning R, Kosheleva I, Srajer V, Kenis PJA, Ren Z. J Appl Cryst. 2014;47:1975–1982. [PMC free article] [PubMed]
32. Pawate AS, Srajer V, Schieferstein J, Guha S, Henning R, Kosheleva I, Schmidt M, Ren Z, Kenis PJA, Perry SL. Acta Crystallogr, Sect F: Struct Biol Commun. 2015;71:823–830. [PMC free article] [PubMed]
33. Guha S, Perry SL, Pawate AS, Kenis PJA. Sens Actuators, B. 2012;174:1–9. [PMC free article] [PubMed]
34. Stellato F, Oberthur D, Liang M, Bean R, Gati C, Yefanov O, Barty A, Burkhardt A, Fischer P, Galli L, Kirian RA, Meyer J, Panneerselvam S, Yoon CH, Cherevinskii F, Speller E, White TA, Betzel C, Meents A, Chapman HN. IUCrJ. 2014;1:204–212. [PMC free article] [PubMed]
35. Yonath A, Harms J, Hansen H, Bashan A, Schlunzen F, Levin I, Koelln I, Tocilj A, Agmon I, Peretz M. Acta Crystallogr, Sect A: Found Crystallogr. 1998;54:945–955. [PubMed]
36. Fry EE, Grimes J, Stuart DI. Mol Biotechnol. 1999;12:13–23. [PubMed]
37. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK. Science. 2007;318:1258–1265. [PMC free article] [PubMed]
38. Cornaby S, Szebenyi DM, Smilgies DM, Schuller DJ, Gillilan R, Hao Q, Bilderback DH. Acta Crystallogr, Sect D: Biol Crystallogr. 2010;66:2–11. [PMC free article] [PubMed]
39. Liu Q, Zhang Z, Hendrickson WA. Acta Crystallogr, Sect D: Biol Crystallogr. 2010;67:45–59. [PMC free article] [PubMed]
40. Liu Q, Liu Q, Hendrickson WA. Acta Crystallogr, Sect D: Biol Crystallogr. 2013;69:1314–1332. [PMC free article] [PubMed]
41. Liu ZJ, Chen L, Wu D, Ding W, Zhang H, Zhou W, Fu ZQ, Wang BC. Acta Crystallogr, Sect A: Found Crystallogr. 2011;67:544–549. [PMC free article] [PubMed]
42. Liu Q, Dahmane T, Zhang ZN, Assur Z, Brasch J, Shapiro L, Mancia F, Hendrickson WA. Science. 2012;336:1033–1037. [PMC free article] [PubMed]
43. Schmidt M, Pande K, Basu S, Tenboer J. Struct Dyn. 2015;2:041708. [PMC free article] [PubMed]
44. Kupitz C, Basu S, Grotjohann I, Fromme R, Zatsepin NA, Rendek KN, Hunter MS, Shoeman RL, White TA, Wang D, James D, Yang JH, Cobb DE, Reeder B, Sierra RG, Liu H, Barty A, Aquila AL, Deponte D, Kirian RA, Bari S, Bergkamp JJ, Beyerlein KR, Bogan MJ, Caleman C, Chao TC, Conrad CE, Davis KM, Fleckenstein H, Galli L, Hau-Riege SP, Kassemeyer S, Laksmono H, Liang M, Lomb L, Marchesini S, Martin AV, Messerschmidt M, Milathianaki D, Nass K, Ros A, Roy-Chowdhury S, Schmidt K, Seibert M, Steinbrener J, Stellato F, Yan L, Yoon C, Moore TA, Moore AL, Pushkar Y, Williams GJ, Boutet S, Doak RB, Weierstall U, Frank M, Chapman HN, Spence JCH, Fromme P. Nature. 2014;513:261–265. [PMC free article] [PubMed]
45. Aquila A, Hunter MS, Doak RB, Kirian RA, Fromme P, White TA, Andreasson J, Arnlund D, Bajt S, Barends TRM, Barthelmess M, Bogan MJ, Bostedt C, Bottin H, Bozek JD, Caleman C, Coppola N, Davidsson J, DePonte DP, Elser V, Epp SW, Erk B, Fleckenstein H, Foucar L, Frank M, Fromme R, Graafsma H, Grotjohann I, Gumprecht L, Hajdu J, Hampton CY, Hartmann A, Hartmann R, Hau-Riege S, Hauser G, Hirsemann H, Holl P, Holton JM, Hömke A, Johansson L, Kimmel N, Kassemeyer S, Krasniqi F, Kühnel KU, Liang M, Lomb L, Malmerberg E, Marchesini S, Martin AV, Maia FRNC, Messerschmidt M, Nass K, Reich C, Neutze R, Rolles D, Rudek B, Rudenko A, Schlichting I, Schmidt C, Schmidt KE, Schulz J, Seibert MM, Shoeman RL, Sierra R, Soltau H, Starodub D, Stellato F, Stern S, Strüder L, Timneanu N, Ullrich J, Wang X, Williams GJ, Weidenspointner G, Weierstall U, Wunderer C, Barty A, Spence JCH, Chapman HN. Opt Express. 2012;20:2706–2716. [PMC free article] [PubMed]
46. Cherezov V, Hanson MA, Griffith MT, Hilgart MC, Sanishvili R, Nagarajan V, Stepanov S, Fischetti RF, Kuhn P, Stevens RC. J R Soc, Interface. 2009;6:S587–S597. [PMC free article] [PubMed]
47. Hunter MS, Segelke B, Messerschmidt M, Williams GJ, Zatsepin NA, Barty A, Benner WH, Carlson DB, Coleman M, Graf A, Hau-Riege SP, Pardini T, Seibert MM, Evans J, Boutet S, Frank M. Scientific Reports. 2014;4:6026. [PMC free article] [PubMed]
48. Zarrine-Afsar A, Barends TR, Mueller C, Fuchs MR, Lomb L, Schlichting I, Miller RD. Acta Crystallogr, Sect D: Biol Crystallogr. 2012;68:321–323. [PubMed]
49. Baxter EL, Aguila L, Alonso-Mori R, Barnes CO, Bonagura CA, Brehmer W, Brunger AT, Calero G, Caradoc-Davies TT, Chatterjee R, DeGrado WF, Fraser JS, Ibrahim M, Kern J, Kobilka BK, Kruse AC, Larsson KM, Lemke HT, Lyubimov AY, Manglik A, McPhillips SE, Norgren E, Pang SS, Soltis SM, Song J, Thomaston J, Tsai Y, Weis WI, Woldeyes RA, Yachandra V, Yano J, Zouni A, Cohen AE. Acta Crystallogr, Sect D: Biol Crystallogr. 2016;72:1–10.
50. Cohen AE, Soltis SM, González A, Aguila L, Alonso-Mori R, Barnes CO, Baxter EL, Brehmer W, Brewster AS, Brunger AT, Calero G, Chang JF, Chollet M, Ehrensberger P, Eriksson TL, Feng Y, Hattne J, Hedman B, Hollenbeck M, Holton JM, Keable S, Kobilka BK, Kovaleva EG, Kruse AC, Lemke HT, Lin G, Lyubimov AY, Manglik A, Mathews II, McPhillips SE, Nelson S, Peters JW, Sauter NK, Smith CA, Song J, Stevenson HP, Tsai Y, Uervirojnangkoorn M, Vinetsky V, Wakatsuki S, Weis WI, Zadvornyy OA, Zeldin OB, Zhu D, Hodgson KO. Proc Natl Acad Sci U S A. 2014;111:17122–17127. [PubMed]
51. Murray TD, Lyubimov AY, Ogata CM, Vo H, Uervirojnangkoorn M, Brunger AT, Berger JM. Acta Crystallogr, Sect D: Biol Crystallogr. 2015;71:1987–1997. [PMC free article] [PubMed]
52. Chavas LMG, Gumprecht L, Chapman HN. Struct Dyn. 2015;2:041709. [PMC free article] [PubMed]
53. Feld GK, Heymann M, Benner WH, Pardini T, Tsai CJ, Boutet S, Coleman MA, Hunter MS, Li X, Messerschmidt M, Opathalage A, Pedrini B, Williams GJ, Krantz BA, Fraden S, Hau-Riege S, Evans JE, Segelke BW, Frank M. J Appl Cryst. 2015;48:1072–1079.
54. Roedig P, Vartiainen I, Duman R, Panneerselvam S, Stübe N, Lorbeer O, Warmer M, Sutton G, Stuart DI, Weckert E, David C, Wagner A, Meents A. Scientific Reports. 2015;5:10451. [PMC free article] [PubMed]
55. Coquelle N, Brewster AS, Kapp U, Shilova A, Weinhausen B, Burghammer M, Colletier JP. Acta Crystallogr, Sect D: Biol Crystallogr. 2015;71:1184–1196. [PMC free article] [PubMed]
56. United States Patent Office. US 2013/0308756. 2013. p. 34.
57. Sierra RG, Gati C, Laksmono H, Dao EH, Gul S, Fuller F, Kern J, Chatterjee R, Ibrahim M, Brewster AS, Young ID, Michels-Clark T, Aquila A, Liang M, Hunter MS, Koglin JE, Boutet S, Junco EA, Hayes B, Bogan MJ, Hampton CY, Puglisi EV, Sauter NK, Stan CA, Zouni A, Yano J, Yachandra VK, Soltis SM, Puglisi JD, Demirci H. Nat Methods. 2016;13:59–62. [PMC free article] [PubMed]
58. Conrad CE, Basu S, James D, Wang D, Schaffer A, Roy-Chowdhury S, Zatsepin NA, Aquila A, Coe J, Gati C, Hunter MS, Koglin JE, Kupitz C, Nelson G, Subramanian G, White TA, Zhao Y, Zook J, Boutet S, Cherezov V, Spence JCH, Fromme R, Weierstall U, Fromme P. IUCrJ. 2015;2:421–430. [PMC free article] [PubMed]
59. Lawrence RM, Conrad CE, Zatsepin NA, Grant TD, Liu H, James D, Nelson G, Subramanian G, Aquila A, Hunter MS, Liang M, Boutet S, Coe J, Spence JCH, Weierstall U, Liu W, Fromme P, Cherezov V, Hogue BG. Struct Dyn. 2015;2:041720. [PMC free article] [PubMed]
60. Liu W, Wacker D, Wang C, Abola E, Cherezov V. Philos Trans R Soc, B. 2014;369:20130314. [PMC free article] [PubMed]
61. Weierstall U, James D, Wang C, White TA, Wang D, Liu W, Spence JCH, Doak RB, Nelson G, Fromme P, Fromme R, Grotjohann I, Kupitz C, Zatsepin NA, Liu H, Basu S, Wacker D, Han GW, Katritch V, Boutet SEB, Messerschmidt M, Williams GJ, Koglin JE, Seibert MM, Klinker M, Gati C, Shoeman RL, Barty A, Chapman HN, Kirian RA, Beyerlein KR, Stevens RC, Li D, Shah STA, Howe N, Caffrey M, Cherezov V. Nat Commun. 2014;5:3309. [PMC free article] [PubMed]
62. Liu W, Wacker D, Gati C, Han GW, James D, Wang D, Nelson G, Weierstall U, Katritch V, Barty A, Zatsepin NA, Li D, Messerschmidt M, Boutet S, Williams GJ, Koglin JE, Seibert MM, Wang C, Shah STA, Basu S, Fromme R, Kupitz C, Rendek KN, Grotjohann I, Fromme P, Kirian RA, Beyerlein KR, White TA, Chapman HN, Caffrey M, Spence JCH, Stevens RC, Cherezov V. Science. 2013;342:1521–1524. [PMC free article] [PubMed]
63. Caffrey M, Li D, Howe N, Shah STA. Philos Trans R Soc, B. 2014;369:20130621. [PMC free article] [PubMed]
64. Adawy A, Rebuffet E, Törnroth-Horsefield S, de Grip WJ, van Enckevort WJP, Vlieg E. Cryst Growth Des. 2013;13:775–781.
65. Carruthers CW, Jr, Gerdts C, Johnson MD, Webb P. PLoS One. 2013;8:e82298. [PMC free article] [PubMed]
66. Garcıa-Ruiz JM, Otálora F, Novella ML, Gavira JA, Sauter C, Vidal O. J Cryst Growth. 2001;232:149–155.
67. Helliwell JR, Chayen NE. Nature. 2007;448:658–659. [PubMed]
68. Kundrot CE, Judge RA, Pusey ML, Snell EH. Cryst Growth Des. 2001;1:87–99.
69. Sauter C, Otálora F, Gavira JA, Vidal O, Giegé R, Garcia-Ruiz JM. Acta Crystallogr, Sect D: Biol Crystallogr. 2001;57:1119–1126. [PubMed]
70. Vaney MC, Maignan S, Ries-Kautt M, Ducruix A. Acta Crystallogr, Sect D: Biol Crystallogr. 1996;52:505–517. [PubMed]
71. Wada H, Hirota N, Matsumoto S, Okada H, Kiyohara M, Ode T, Tanokura M, Nakamura A, Ohtsuka J, Kita A, Numoto N, Kashiwagi T, Suzuki EI. Phys Procedia. 2012;36:953–957.
72. Unger MA, Chou HP, Thorsen T, Scherer A, Quake SR. Science. 2000;288:113–116. [PubMed]
73. Perry SL, Roberts GW, Tice JD, Gennis RB, Kenis PJA. Cryst Growth Des. 2009;9:2566–2569. [PMC free article] [PubMed]
74. Madou M, Zoval J, Jia G, Kido H, Kim J, Kim N. Annu Rev Biomed Eng. 2006;8:601–628. [PubMed]
75. Du W, Li L, Nichols KP, Ismagilov RF. Lab Chip. 2009;9:2286–2292. [PMC free article] [PubMed]
76. Shim JU, Cristobal G, Link DR, Thorsen T, Jia Y, Piattelli K, Fraden S. J Am Chem Soc. 2007;129:8825–8835. [PMC free article] [PubMed]
77. Greaves ED, Manz A. Lab Chip. 2005;5:382–391. [PubMed]
78. Maeki M, Pawate AS, Yamashita K, Kawamoto M, Tokeshi M, Kenis PJA, Miyazaki M. Anal Chem. 2015;87:4194–4200. [PubMed]
79. Maeki M, Yamaguchi H, Tokeshi M, Miyazaki M. Analytical Sciences. 2016;32:3–9. [PubMed]
80. Chirgadze NY, Kisselman G, Qiu W, Romanov V, Thompson CM, Lam R, Battaile KP, Pai EF. In: Recent Advances in Crystallography. Benedict JB, editor. InTech; 2012. pp. 87–96.
81. Kisselman G, Qiu W, Romanov V, Thompson CM, Lam R, Battaile KP, Pai EF, Chirgadze NY. Acta Crystallogr, Sect D: Biol Crystallogr. 2011;67:533–539. [PMC free article] [PubMed]
82. Dhouib K, Khan Malek C, Pfleging W, Gauthier-Manuel B, Duffait R, Thuillier G, Ferrigno R, Jacquamet L, Ohana J, Ferrer J-L, Théobald-Dietrich A, Giegé R, Lorber B, Sauter C. Lab Chip. 2009;9:1412–1421. [PubMed]
83. Stojanoff V, Jakoncic J, Oren DA, Nagarajan V, Navarro Poulsen JC, Adams-Cioaba MA, Bergfors T, Sommer MO. Acta Crystallogr, Sect F: Struct Biol Cryst Commun. 2011;67:971–975. [PMC free article] [PubMed]
84. Emamzadah S, Petty TJ, De Almeida V, Nishimura T, Joly J, Ferrer JL, Halazonetis TD. Acta Crystallogr, Sect D: Biol Crystallogr. 2009;65:913–920. [PMC free article] [PubMed]
85. Ng JD, Clark PJ, Stevens RC, Kuhn P. Acta Crystallogr, Sect D: Biol Crystallogr. 2008;64:189–197. [PubMed]
86. Gerdts CJ, Elliott M, Lovell S, Mixon MB, Napuli AJ, Staker BL, Nollert P, Stewart L. Acta Crystallogr, Sect D: Biol Crystallogr. 2008;64:1116–1122. [PubMed]
87. Steinert CP, Mueller-Dieckmann J, Weiss M, Roessle M, Zengerle R, Koltay P. IEEE. 2007. pp. 561–564.
88. Sauter C, Dhouib K, Lorber B. Cryst Growth Des. 2007;7:2247–2250.
89. Anderson MJ, DeLaBarre B, Raghunathan A, Palsson BO, Brunger AT, Quake SR. Biochemistry. 2007;46:5722–5731. [PubMed]
90. Hansen CL, Classen S, Berger JM, Quake SR. J Am Chem Soc. 2006;128:3142–3143. [PubMed]
91. Anderson MJ, Hansen CL, Quake SR. Proc Natl Acad Sci U S A. 2006;103:16746–16751. [PubMed]
92. Axford D, Foadi J, Hu NJ, Choudhury HG, Iwata S, Beis K, Evans G, Alguel Y. Acta Crystallogr, Sect D: Biol Crystallogr. 2015;71:1228–1237. [PMC free article] [PubMed]
93. Soliman AS, Warkentin M, Apker B, Thorne RE. Acta Crystallogr, Sect D: Biol Crystallogr. 2011;67:646–656. [PMC free article] [PubMed]
94. le Maire A, Gelin M, Pochet S, Hoh F, Pirocchi M, Guichou JF, Ferrer JL, Labesse G. Acta Crystallogr, Sect D: Biol Crystallogr. 2011;67:747–755. [PubMed]
95. Jacquamet L, Ohana J, Joly J, Borel F, Pirocchi M, Charrault P, Bertoni A, Israel-Gouy P, Carpentier P, Kozielski F, Blot D, Ferrer JL. Structure. 2004;12:1219–1225. [PubMed]
96. Watanabe N, Murai H, Tanaka I. Acta Crystallogr, Sect D: Biol Crystallogr. 2002;58:1527–1530. [PubMed]
97. Holton JM, Frankel KA. Acta Crystallogr, Sect D: Biol Crystallogr. 2010;66:393–408. [PMC free article] [PubMed]
98. Wierman JL, Alden JS, Kim CU, McEuen PL, Gruner SM. J Appl Cryst. 2013;46:1501–1507. [PMC free article] [PubMed]
99. Warren AJ, Crawshaw AD, Trincao J, Aller P, Alcock S, Nistea I, Salgado PS, Evans G. Acta Crystallogr, Sect D: Biol Crystallogr. 2015;71:2079–2088. [PMC free article] [PubMed]
100. Wirtz C, Berner NC, Duesberg GS. Adv Mater Interfaces. 2015;2:1500082.
101. Mohanty N, Fahrenholtz M, Nagaraja A, Boyle D, Berry V. Nano Letters. 2011;11:1270–1275. [PubMed]
102. Kim HW, Yoon HW, Yoon SM, Yoo BM, Ahn BK, Cho YH, Shin HJ, Yang H, Paik U, Kwon S, Choi JY, Park HB. Science. 2013;342:91–95. [PubMed]
103. Li X, Cai W, An J, Kim S, Nah J, Yang D, Piner R, Velamakanni A, Jung I, Tutuc E, Banerjee SK, Colombo L, Ruoff RS. Science. 2009;324:1312–1314. [PubMed]
104. Li X, Zhu Y, Cai W, Borysiak M, Han B, Chen D, Piner RD, Colombo L, Ruoff RS. Nano Letters. 2009;9:4359–4363. [PubMed]
105. Chang CC, Kolewe KW, Li Y, Kosif I, Freeman BD, Carter KR, Schiffman JD, Emrick T. Adv Mater Interfaces. 2016;3:1500521.
106. Pérez-Mitta G, Tuninetti JS, Knoll W, Trautmann C, Toimil-Molares ME, Azzaroni O. J Am Chem Soc. 2015;137:6011–6017. [PubMed]
107. Acevedo-Cartagena DE, Zhu J, Trabanino E, Pentzer E, Emrick T, Nonnenmann SS, Briseno AL, Hayward RC. ACS Macro Lett. 2015;4:483–487.
108. Graber T, Anderson S, Brewer H, Chen YS, Cho HS, Dashdorj N, Henning RW, Kosheleva I, Macha G, Meron M, Pahl R, Ren Z, Ruan S, Schotte F, Srajer V, Viccaro PJ, Westferro F, Anfinrud P, Moffat K. Journal of Synchrotron Radiation. 2011;18:658–670. [PMC free article] [PubMed]
109. Bailey S. Acta Crystallogr, Sect D: Biol Crystallogr. 1994;50:760–763. [PubMed]
110. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW. Acta Crystallogr, Sect D: Biol Crystallogr. 2010;66:213–221. [PMC free article] [PubMed]
111. Ilavsky J. J Appl Cryst. 2012;45:324–328.
112. Hubbell JH, SSM . Tables of X-ray Mass Attenuation Coefficients and Mass Energy-Absorption Coefficients from 1 keV to 20 MeV for Elements Z=1 to 92 and 48 Additional Substances of Dosimetric Interest. National Institute of Standards and Technology; 1996.
113. Chai D, Xie Z, Wang Y, Liu L, Yum YJ. ACS Appl Mater Interfaces. 2014;6:17974–17984. [PubMed]
114. Nunes PS, Ohlsson PD, Ordeig O, Kutter JP. Microfluid Nanofluid. 2010;9:145–161.
115. Khvostichenko DS, Kondrashkina E, Perry SL, Pawate AS, Brister K, Kenis PJA. Analyst. 2013;138:5384–5395. [PMC free article] [PubMed]
116. Khvostichenko DS, Schieferstein JM, Pawate AS, Laible PD, Kenis PJA. Cryst Growth Des. 2014;14:4886–4890. [PMC free article] [PubMed]
117. Kondrashkina E, Khvostichenko DS, Perry SL, Osinski JV, Kenis PJA, Brister K. J Phys: Conf Ser. 2013;425:012013. [PMC free article] [PubMed]
118. Warkentin M, Hopkins JB, Badeau R, Mulichak AM, Keefe LJ, Thorne RE. Journal of Synchrotron Radiation. 2013;20:7–13. [PMC free article] [PubMed]
119. Ren Z, Chan PWY, Moffat K, Pai EF, Royer WE, Srajer V, Yang X. Acta Crystallogr, Sect D: Biol Crystallogr. 2013;69:946–959. [PMC free article] [PubMed]